WanjinH Profile Banner
Wanjin Hong Profile
Wanjin Hong

@WanjinH

Followers
504
Following
513
Statuses
3K

A simple man finding his ways in a complex world

Singapore
Joined July 2016
Don't wanna be here? Send us removal request.
@WanjinH
Wanjin Hong
@WanjinH
13 hours
Bain Bets Big on Japanese Market With $3.3B Tanabe Buy
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
13 hours
BMS Positions Breyanzi for Another Indication as LOE Woes Mount
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
2 days
Paul Krugman says the AI boom reminds him of the dot-com bubble and predicts it may end with a 'giant tech-bro bailout' via @businessinsider
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
4 days
Nasdaq Neophytes Acelyrin, Alumis Merge to Tackle Immune-Mediated Diseases
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
4 days
Regeneron Sues Sanofi, Alleging Stonewalling in Dupixent Pact
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
4 days
As US Sales of Leqembi Lag, Eisai Eyes SubQ Approvals
0
0
1
@WanjinH
Wanjin Hong
@WanjinH
6 days
The Top 7 Biopharma Licensing Deals of 2024
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
6 days
GSK Looks to Deal in Cancer, Respiratory, Inflammation in 2025
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
6 days
Despite Doubled Wegovy Sales, Novo Executives Confront Analysts’ Insatiable Appetite
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
6 days
Regeneron Misses on Eylea, Dupixent Sales; Issues First-Ever Dividends
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
7 days
@yalepathology @RongFan8 @MinaXu7 @YaleMed @TheMarkFdn warmest congrats
0
0
2
@WanjinH
Wanjin Hong
@WanjinH
7 days
The recent advances and implications in cancer therapy for the hippo p...
0
0
1
@WanjinH
Wanjin Hong
@WanjinH
8 days
Pfizer Sees Path to Braftovi’s Full Approval With Phase III CRC Data
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
8 days
Trump’s Tariffs Threaten Big Pharma With Higher Costs and Slimmer Margins
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
9 days
GPT-4b Enters The Laboratory: OpenAI’s New Model Takes On Longevity Science via @WorldHealth_Net
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
11 days
Takeda Drops Epilepsy Drug, Names New CEO Amid Q3 Earnings
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
11 days
Novartis Eyes More Bolt-On Deals in 2025 as Q4 Earnings Easily Beat Consensus
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
12 days
Layoff Tracker: To Extend Cash Runway, Zentalis Will Lay Off 40% of Staff
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
12 days
Roche to Stay ‘Disciplined’ With Deals in 2025
0
0
0
@WanjinH
Wanjin Hong
@WanjinH
12 days
Alibaba releases AI model it says surpasses DeepSeek
0
0
0